Lugano, Switzerland

Alberto Bernareggi

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Altergon Sa. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Bernareggi. Retrieved from https://idiyas.com/inventor/alberto-bernareggi-w1jocgae

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Alberto Bernareggi

Introduction

Alberto Bernareggi is a notable inventor based in Lugano, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of steroid hormones. With a total of three patents to his name, Bernareggi's work focuses on enhancing the bioavailability of oral hormone solutions.

Latest Patents

Bernareggi's latest patents include innovative aqueous oral solutions of steroid hormones, specifically Progesterone and Testosterone, complexed with hydroxypropyl-β-cyclodextrin (HPβCD). These formulations are designed for oral administration and are characterized by a specific molar ratio that ensures high hormone plasma levels. The optimization of solubility, permeability, metabolic stability, and bioavailability allows for effective plasma concentrations following oral administration of lower doses compared to existing formulations on the market, such as Prometrium and Andriol. This advancement not only enhances patient safety but also improves compliance.

Career Highlights

Alberto Bernareggi is associated with Altergon SA, where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the therapeutic use of steroid hormones, making significant strides in patient care and treatment efficacy.

Collaborations

Bernareggi collaborates with talented professionals in his field, including Nadia Puppini and Alessandro Nencioni. Their combined expertise contributes to the success of their innovative projects.

Conclusion

Alberto Bernareggi's contributions to the field of pharmaceutical formulations demonstrate his commitment to improving patient outcomes through innovative solutions. His patents reflect a deep understanding of the complexities involved in hormone therapy, paving the way for safer and more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…